Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 28, 2022, 11:07 pm
Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing
Curated, Global, Hometown News for the City and Citizens of Santa Monica California
Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dog Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
COPYRIGHT © Indian Hill Media Inc. Another Smiling Dow Web Development. Hosted by InlandEmpire.IO ALL RIGHTS RESERVED.
